A case series of intertriginous rashes in cancer patients
Abstract
Introduction: Immunocompromised patients, especially those with cancer, face an elevated risk of developing inflamed and painful rashes between the skinfolds. These intertriginous conditions are not always easy to identify.
Case Series: We report a case series of three neutropenic patients, two with acute myeloblastic leukemia (AML) and one with metastatic left invasive ductal carcinoma, presenting to the hospital dermatology consult team with intertriginous skin eruptions. The patients were diagnosed with symmetrical drug-related intertriginous and flexural exanthema (SDRIFE), ecthyma gangrenosum, and toxic erythema of chemotherapy. Treatment and management of these cases involved topical steroids, antibiotics, and chemotherapy dosing adjustment.
Conclusion: This paper explores the various infectious, inflammatory, and other etiologies of intertriginous rashes in immunocompromised and neutropenic patients.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.